why choose us

First received: September 12, 2022

Clinical Trial: Trial of Suvorexant for Sleep in Children With Autism

Study Status: Completed

Recruit Status: RECRUITING

Condition: Autism

Study Type: INTERVENTIONAL


Official Title: Randomized Placebo-Controlled Crossover Trial of Suvorexant for Sleep in Children With Autism

Brief Summary: The purpose of this study is to examine the effect of suvorexant on sleep in children and adolescents with Autism Spectrum Disorder (ASD).Suvorexant is a selective, dual orexin receptor antagonist (DORA) used for the treatment of sleep onset difficulties and/or sleep maintenance.To accomplish this, the investigators will use a randomized double-blind placebo-controlled crossover 8-week study design to examine the effect of suvorexant on sleep physiology as assessed by polysomnography (PSG), actigraphy,…

Read more